Kaiser Permanente is set to exit AtheroMed when Volcano Corporation buys the medical device maker in a deal that could potentially rise to $130m.

Volcano Corporation, a manufacturer of medical tools to treat heart disease, has agreed to acquire AtheroMed, the developer of a system to treat peripheral artery disease for $115m, granting an exit to Kaiser Permanente Ventures.

The corporate venturing arm of managed care consortium Kasier Permanente invested in a $4.5m round for AtheroMed in 2012 together with Canaan Partners and US Venture Partners, and a $6m round in April 2013 that featured those venture capital firms as well as Vertical Group.

…